Alcohol Dependence Clinical Trial
Official title:
Primary Care Based Disease Management for Alcohol Dependence
A randomized study of Alcohol Care Management for the treatment of alcohol dependence in primary care settings.
Background: Alcohol dependence is one of the leading causes of disability worldwide. Despite
the availability of efficacious treatments less than 20% of individuals with alcohol
dependence are actively engaged in treatment. Within the VA system systematic screening was
implemented to increase the identification of patients with both abuse and dependence.
However, there continues to be a marked discrepancy in the care offered or accessed among
those identified with alcohol dependence. Existing treatment guidelines suggest that all
persons with dependence receive care in specialty addiction treatment. Data from our center
indicate that among those individuals screened in primary care who have AUDIT - C scores of
>7, only 30% are formally evaluated with 50% receiving only brief advice and 20% having no
evidence of assessment or referral. Of those assessed and referred to specialty care only
60% attend an initial visit and only 33% meet the EPRP performance measure of 2 visits per
month for 90 days. This disparity in treatment access exists even though Veterans self
report a desire to cut down and readiness to change drinking behaviors. (VA ACQUIP) and a
willingness to consider pharmacotherapy.
Aims: Available evidence suggests that primary care may be a key component in the
identification of alcohol dependent patients, delivery of initial interventions, and to the
success of addiction treatment. Indeed, the vast majority of screening and new case
identification occurs within primary care. The primary aims of this proposal are to test the
effectiveness of a primary care based Alcohol Care Management (ACM) program and to evaluate
the barriers and facilitators to accessing and engaging individuals into treatment. The ACM
program uses a Behavioral Health Specialist to deliver care focused on the use of
pharmacotherapy in combination with psychosocial support (Medication Management). This model
may overcome barriers to care such as frequent intensive visit schedules often required in
specialty settings, stigma associated with specialty care or group therapy approaches,
access to specialty care in remote areas, and the current focus on a 12 step model of
treatment. Secondary aims are to establish the acceptability of primary care based
treatments and defining treatment modifiers such as age, barriers, co-occurring depression,
and pharmacogenetic response.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03340051 -
Remote Alcohol Monitoring and Episodic Thinking
|
N/A | |
Completed |
NCT02901041 -
Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism
|
Phase 3 | |
Not yet recruiting |
NCT06444243 -
Psilocybin-assisted Therapy for Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02486900 -
Neurofeedback & Alcohol Dependence
|
N/A | |
Completed |
NCT02705898 -
Lifestyle Physical Activity Intervention for Depressed Alcohol Dependent Women
|
N/A | |
Completed |
NCT02197598 -
Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use
|
Phase 4 | |
Completed |
NCT02179749 -
Mifepristone Treatment of Alcohol Use Disorder
|
Phase 2 | |
Recruiting |
NCT02385643 -
The Efficacy of A Smartphone-based Support System to Reinforce Alcohol Abstinence in Treatment-seeking Patients
|
N/A | |
Completed |
NCT01828866 -
Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent Patients
|
N/A | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Active, not recruiting |
NCT01182766 -
New Treatment for Alcohol and Nicotine Dependence
|
Phase 2/Phase 3 | |
Completed |
NCT01342549 -
Treatment Strategy for Alcohol Use Disorders in Veterans With TBI
|
Phase 3 | |
Completed |
NCT02193204 -
Chronic Alcohol, Stress Inflammatory Response and Relapse Risk
|
N/A | |
Completed |
NCT01165541 -
A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency
|
Phase 2 | |
Completed |
NCT01176591 -
HBPL Study of the Impact of the NK1 Antagonist Aprepitant
|
Phase 2 | |
Completed |
NCT00585780 -
Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse
|
Phase 1/Phase 2 | |
Completed |
NCT01056484 -
Mindfulness Meditation for Health
|
Phase 2 | |
Completed |
NCT00607620 -
Disseminating Organizational SBI Services at Trauma Centers
|
N/A | |
Completed |
NCT00884884 -
Aripiprazole and Topiramate on Free-Choice Alcohol Use
|
Phase 2/Phase 3 | |
Completed |
NCT00463346 -
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
|
Phase 3 |